CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 233 filers reported holding CLOVIS ONCOLOGY INC in Q1 2018. The put-call ratio across all filers is 0.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $45,000 | -15.1% | 1,000 | 0.0% | 0.02% | -5.9% |
Q1 2018 | $53,000 | -23.2% | 1,000 | -1.5% | 0.02% | -22.7% |
Q4 2017 | $69,000 | -24.2% | 1,015 | -7.7% | 0.02% | -26.7% |
Q3 2017 | $91,000 | -12.5% | 1,100 | -1.3% | 0.03% | -23.1% |
Q2 2017 | $104,000 | -26.2% | 1,115 | -49.7% | 0.04% | -29.1% |
Q1 2017 | $141,000 | +43.9% | 2,215 | 0.0% | 0.06% | +34.1% |
Q4 2016 | $98,000 | -44.0% | 2,215 | -54.5% | 0.04% | -46.8% |
Q3 2016 | $175,000 | +161.2% | 4,865 | 0.0% | 0.08% | +148.4% |
Q2 2016 | $67,000 | +31.4% | 4,865 | +81.8% | 0.03% | +10.7% |
Q1 2016 | $51,000 | -42.7% | 2,676 | +5.5% | 0.03% | -45.1% |
Q4 2015 | $89,000 | -21.9% | 2,536 | +104.0% | 0.05% | -29.2% |
Q3 2015 | $114,000 | +12.9% | 1,243 | +8.1% | 0.07% | +16.1% |
Q2 2015 | $101,000 | – | 1,150 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,402,781 | $231,389,000 | 9.96% |
Versant Venture Management, LLC | 101,855 | $6,926,140,000 | 7.29% |
Avoro Capital Advisors LLC | 1,102,884 | $74,996,000 | 4.86% |
Redmile Group, LLC | 1,320,027 | $89,762,000 | 3.90% |
NEXTHERA CAPITAL LP | 233,200 | $15,858,000 | 2.92% |
Iguana Healthcare Management, LLC | 60,000 | $4,080,000 | 2.66% |
HealthCor Management, L.P. | 973,840 | $66,221,000 | 2.16% |
Casdin Capital, LLC | 127,500 | $8,670,000 | 2.11% |
Prosight Management, LP | 40,000 | $2,720,000 | 2.00% |
Camber Capital Management LP | 600,000 | $40,800,000 | 2.00% |